← Back to LEXX

Lexaria Bioscience Corp. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSMay 2026Filed 13/07/2026Feb 2026Filed 13/07/2026Nov 2025Filed 13/07/2026May 2025Filed 13/07/2026Feb 2025Filed 13/07/2026Nov 2024Filed 13/07/2026May 2024Filed 14/07/2025Feb 2024Filed 14/07/2025
$0$0$0$0.2$0.2$0.2$0.1$0.1
−$2−$1.4−$1.6−$3.8−$2.7−$2.7−$1.8−$0.6
−$0.08−$0.06−$0.07−$0.21−$0.15−$0.16−$0.13−$0.06
2524211818171411

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.